APOE and atherosclerosis: Additionally, Keul et al. (2022) recently highlighted that treatment with 4-deoxypyridoxine (DOP) accelerated the development of atherosclerosis in a cholesterol-fed ApoE−/− mouse model, leading to the predominant formation of an unstable plaque phenotype characterized by frequent plaque rupture and atherosclerotic thrombosis.